In addition, CSF sTREM2 levels are positively associated with levels of CSF T-tau in individuals with FTD and also with P-tau in individuals with likely AD pathology, and they are influenced by both age and disease duration. The gene discussed is MAPT; the disease is frontotemporal dementia.